Antibiotics Flashcards

(29 cards)

1
Q

What antibiotics place someone at risk of C diff?

A

4C’s - clindamycin, cephalosporin, co-amoxiclav

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Antibiotics which inhibit cell wall synthesis?

A

penicillin
cephalosporins
carbapenems
vancomycin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Antibiotics which inhibit folic acid metabolism?

A

trimethoprim

sulphonamides

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Mechanism of action of ciprofloxacin?

A

DNA gyrase inhibitor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Mechanism of action of rifampicin?

A

DNA directed RNA polymerase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Inhibit protein synthesis - 50S

A

erythromycin
clindamycin
chloramphenicol

macrolides

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Inhibit protein synthesis - 30S

A

Gentamicin
Amikacin
tetracycline
linezolid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Antibiotics which are bacteriostatic

A

ECSTaTiC

erythromycin
clindamycin
sulfamethoxazole
trimethoprim
tetracycline
chloramphenicol
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Antibiotics which are bacteriocidal

A

Very Finely Proficient At Cell Murder

V - vancomycin
F - fluoroquinolones
P - penicillin
A - aminoglycosides
C - cephalosporins
M - metronidazole
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What antibiotics to avoid in someone who is breastfeeding?

A

nitrofurantoin - may cause hemolysis in G6PD infants

ciprofloxacin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Prosthetic joint infection

  • antibiotic with good bone penetration
  • antibiotic with good biofilm penetration
A

bone - fluoroquinolones

biofilm - rifampicin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Indications for change from IV to oral route for antibiotics

A

Apyrexial for 48 hours (<38C) and no unexplained tachycardia
clinical improvement
oral diet tolerated and no impaired GI absorption
WBC and CRP improving
suitable oral alternative

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Indications for meropenem

A

Febrile neutropenia (haematology/oncology sepsis protocol)

2/3rd line treatment for ventilator associated pneumonia or sepsis in ITU setting

neurosurgical patients
exacerbation of CF or bronchiectasis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q
Linezolid 
what is it good for?
Indications?
SE
route
A

Gram+ve: MRSA, VRE

pneumonia, bacteraemia

Prolonges used: bone marrow suppression, optic neuropathy

oral or IV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q
Daptomycin
what is it good for?
Indications?
SE
route
A

Gram +ve: S aureus, VRE

SSTI

SE: myositis, rhabdomyolysis

Inactivated by lung surfactant
IV only

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Beta-lactams

  • examples
  • mechanism of action
  • caution
  • clinical uses
  • SE
A

Penicillin 

Cephalosporins: 1st, 2nd and 
3rd generation 

Anti-pseudomonal penicillins 

B-lactam and beta-lactamase inhibitor combinations 

Carbapenems 


Mechanism of action = Target PBP → stops peptidoglycan production leads to cell lysis (bactericidal)
- Inhibits enzymes that catalyse the final step in bacterial cell wall assembly

Caution - Renal excretion: adjust dose in renal impairment

Mechanisms of resistance

  1. Altered PBP - target reduced affinity binding (mecA in S. aureus = MRSA)
  2. Destruction by beta-lactamase (some can be overcome by also giving beta-lactamase inhibitor)
  3. Gram –ve: altered outer membrane proteins → reduced penetration
  4. Gram –ve: efflux pumps

Clinical examples Penicillin
Cellulitis - Expect: S. aureus; Streptococci; Use: flucloxacillin

Community-acquired pneumonia
- Expect: S. pneumonia; H. influenza
Use: Amoxicillin (empirically; until +ve culture) or co-amoxiclav based on CURB-65 score (+/- clarithromycin)

Proven sensitive S. aureus infection

  • E.g. infective endocarditis, bone & joint infection
  • MSSA – not MRSA
  • Use: Flucloxacillin (superior choice in non-penicillin allergic patients)

Asplenic? - Lifelong penicillin V prophylaxis against S. pneumonia & N meningitides & Vaccines

Penicillin SE (similar for all beta-lactams)
Allergy - Skin rashes <10%; anaphylaxis <0.4%
Liver injury - Cholestasis or hepatitis
- Esp. flucloxacillin (hepatitis) & co-amoxiclav (cholestasis)
Interstitial nephritis - Microscopic haematuria, leucocyturia, high creatinine, low GFR
Antibiotic-associated diarrhoea

17
Q

Piperacillin

  • good against
  • mechanism of action
  • clinical uses
A

Anti-pseudomonal penicillins

Good against P. aeruginosa

P. aeruginosa = inherently drug resistant vie efflux pumps, altered microbial targets (e.g. topoisomerase) and production of beta-lactamases and enzymes that inactivate aminoglycosides

Comes in combination with Tazobactam (beta-lactamase inhibitor) = piperacillin-tazobactam (aka Tazocin)

Use: hospital acquired pneumonia, intra-abdominal infection, neutropenic sepsis, proven P. aeruginosa infection

18
Q

Glycopeptides

  • examples
  • mechanism of action
  • good against? bad for?
  • caution
  • clinical uses (IV, oral)
  • SE
A

Vancomycin (& teicoplanin)

Mechanism of action = Cell wall synthesis inhibition – prevent elongation of peptidoglycan chain by binding to D-alanyl-D-alanine tail of peptides

Spectrum
- Gram +ve; MRSA
NOT for gram –ve; VRE

IV
Severe MRSA infections (consider in nosocomial infection)
Gram +ve infections in penicillin-allergic patients
Pencillin-resistant S. pneumonia

Oral = c. difficile infection

Vancomycin

  • Measure trough levels to guide dosing and dosing interval
  • IV - systemic infection – no useful oral bioavailability
  • Bactericidal
  • Time dependent killing – want to be giving it as often as possible so reduce dose rather than increase dosing interval
  • Renal excretion

SE

  • Nephrotoxic – monitor renal biochem
  • Ototoxic
  • ‘Red man’ syndrome (if this occurs then decrease infusion rate)
19
Q

Aminoglycosides

  • examples
  • mechanism of action
  • good against? bad for?
  • caution
  • clinical uses
  • SE
A

• Irreversible inhibition of protein synthesis
o Binds to 30S subunit of prokaryotic ribosome → interferes with mRNA translation
o O2 dependent transport – not for anaerobes
o Good against gram -ve
• Gentamicin
o Bactericidal; IV (poor oral absorption)
• Concentration dependent killing
• Renal excretion
✓ Gram –ve: Pseudomonas, S. aureus (some MRSA), enterococci
Some resistance: gram –ve, many gram +ve
o Empiric therapy – for gram –ve cover
• Sepsis of unknown origin - bacteraemia
• UTI – cystitis, pyelonephritis
• Neutropenic sepsis
o Synergistically with beta lactams/ vancomycin in endocarditis
o SE:
• Nephrotoxic (5-25%)
• Ototoxic (may be irreversible)
• Worsen myasthenia gravis – So avoid in MG
o Monitor trough levels; renal biochemistry; ask daily about tinnitus and vestibular signs (levels don’t correlate with toxicity)
o Do not use for >72 hours without discussion with micro (high risk ototoxicity)
• Routes: im or IV, topical
• PK
o Vd = ECS (25% body weight)
o Adjust maintenance dosing based upon [creatinine]
o Plasma monitoring necessary
• Used
o Pneumonia, MRSA, wide variety of Gram –ve & some gram +ve bacteria
o Upper resp. tract procedures

o	Endocarditis
o	Bacteremia, sepsis
o	Skin infections (topical)
o	UTIs
o	GI / GU procedures 

• SE:
o Ototoxicity; Nephrotoxicity
o Vestibular toxicity - May be reversible; Not able to walk in straight line
o NMJ blockade (high dose)
o Pregnancy – used with caution - Cat C (8th nerve) – baby’s ear
• Resistance - Aminoglycoside modifying enzymes; Modified binding site; Efflux pump

20
Q

Quinolones

  • examples
  • mechanism of action
  • good against? bad for?
  • caution
  • clinical uses
  • SE
A

Ciprofloxacin; Levofloxacin; Moxifloxacin

Interfere with bacterial nucleic acid synthesis by inhibiting
• Bacterial DNA gyrase (DNA supercoiling) in gram –ve
• Topoisomerase IV (DNA relaxation) in gram +ve

Ciprofloxacin
• Bactericidal
o Oral or IV
o Reach high conc. in lung, bile, prostate
o Renal excretion +/- hepatic metabolism
• ✓ Gram –ve: Pseudomonas
• ✓ Atypical pneumonia organisms (Chlamydophila, mycoplasma, legionella) & TB
• ✓ Some S. aureus (inc. MRSA), anthrax
• NOT good for many gram +ve
• Clinical use
o Atypical pneumonia organisms
o Pseudomonas in CF
o Gram –ve bone and joint infections
o Pyelonephritis
o Prostatitis
o Gonorrhoea
• SE
o Diarrhoea, nausea & vomiting (common)
o Reduced seizure threshold (NOT suitable in epilepsy)
o Tendon rupture (don’t use in children)
o QT interval prolongation – consider getting baseline ECG
o High risk of precipitating C. difficile infection

21
Q

Macrolides

  • examples
  • mechanism of action
  • good against? bad for?
  • caution
  • clinical uses
  • SE
A

• Inhibit protein synthesis by preventing peptide chain elongation - bind to 50S ribosomal sub-unit (causing dissociation of peptidyl-tRNA from the ribosome) → bacteriostatic
• Clarithromycin; Erythromycin; Azithromycin
o Once a day; Oral or IV
o Good intracellular penetration
o Hepatic metabolism → P450 enzyme inducer
• Use:
o Community acquired pneumonia
• CURB65≥2 (+ amoxicillin) for atypical organism cover
• CURB 65 0-1 if penicillin allergic
o Skin infection - Mild cellulitis if penicillin allergic
o H pylori eradication (+ amoxicillin + PPI)
o STIs
• Similar spectrum to penicillin – so good in patients with penicillin allergy
✓ Gram +ve
• Staph aureus
• Strep. Pneumoniae
• Group B streptococcus
• Bordetella pertussis
• C difficile
• Non-tuberculous mycobacteria (Mycobacterium avium-intracellulare) – immunocompromised patients
✓ Gram –ve

  • Campylobacter
  • N gonorrhoeae
  • Chlamydia
  • Legionella pneumophila
  • Rickettsia
  • Salmonella typhi
  • H pylori
  • Listeria

✓ Atypical pneumonia organisms – Chlamydophila, Mycoplasma, legionella
✓ Lyme disease – Borrelia burgdoferi
✗ most gram -ve
• SE:
o GI upset (diarrhoea, nausea, vomiting)
o Hepatotoxicity
o Rash
o Increase QT (do baseline ECG & check if other drugs also have this SE)
o Thrombophlebitis (IV)
o If administered with statin – higher risk of myositis – so stop statin
o Erythromycin – nausea
• Resistance - Efflux pump; Modified binding site

22
Q

Lincosamides

  • examples
  • mechanism of action
  • good against? bad for?
  • caution
  • clinical uses
  • SE
A

Clindamycin

Inhibit protein synthesis by preventing peptide chain elongation via binding to 50S ribosomal sub-unit (causing dissociation of peptidyl-tRNA from the ribosome)
•	Bacteriostatic
•	Oral or IV
•	Good tissue penetration – esp bone
•	Liver &amp; renal excretion

✓ Gram +ve: S aureus, streptococci
✓ Anaerobes
✓ Pneumocystis jirovecii
✓ Plasmodium falciparum malaria

✗ Most gram -ve

Use:
• S aureus bone & joint infection
o Not 1st /2nd line due to risk of C difficile
• Necrotising fasciitis (or very severe soft tissue infection)
o Needs urgent surgical debridement
o Clindamycin (+flucloxacillin + ben-pen + gentamicin + metronidazole)

SE:
•	Diarrhoea
•	Rash
•	Hepatotoxicity
•	Leucopenia &amp; thrombocytopenia
•	High risk of precipitating C. difficile infection
23
Q

Tetracyclines

  • examples
  • mechanism of action
  • good against? bad for?
  • caution
  • clinical uses
  • SE
A

Tetracyline (1st G)
Doxycyline (2nd G)
Tigecycline (3rd G)

Bacteriostatic – inhibit protein synthesis by blocking tRNA binding via reversibly binding to 30S ribosomal sub-unit

Tetracycline
•	Chlamydia trachomatis
o	Eye infection (trachoma), urethritis, LGV
•	Respiratory tract infection:
o	Chlamydia psittacosis
o	Mycoplasma pneumonia  (but usually use clarithromycin)
•	Pharma
o	Oral 
o	Renal excretion
•	SE
o	Nausea, vomiting, diarrhoea
o	Oesophageal irritation
o	Photosensitivity
o	Deposited in growing bones/teeth (avoid in <12 yo and pregnant/breastfeeding women)
o	Hepatotoxicity
o	Exacerbate renal impairment (not doxycycline)
o	Idiopathic intracranial hypertension
Doxycycline 
•	Broad spectrum
•	Uses:
o	Resp. tract infection → CAP; HAP; COPD; LRTI
•	Haemophilus influenzae
•	Staph. Aureus
•	Moraxella catarrhalis
•	E coli
•	Klebsiella pneumoniae
o	Mild MRSA cellulitis 
o	Bacterial pneumonia, acne vulgaris, sinusitis, SSTI (good against staph)
o	Atypical pneumonias – chlamydia, mycoplasma
o	STI – chlamydia, LGV, syphilis
o	Insect borne infections – rickettsia, borrelia
•	Oral agent
•	GI excretion
•	Good tissue penetration
•	Variable resistance
o	Gram –ve: E coli, Enterobacter, Klebsiella, Haem influenza
o	Gram +ve: Strep pyogenes, Strep pneumonia, Staph aureus
•	Problems
o	Phototoxicity
o	Upper GI symptoms
o	Secondary intracranial hypertension
o	Teratogenicity
o	Teeth discolouration

Tigecycline
• Broad spectrum
• MRSA, VRE

24
Q

Trimethoprim

  • examples
  • mechanism of action
  • good against? bad for?
  • caution
  • clinical uses
  • SE
A

• Interferes with folate synthesis by inhibiting bacterial dihydrofolate reductase
o May be bacterio-static or –cidal
o Oral
o Good tissue penetration – kidney, lung, sputum, prostate
o Renal excretion
o Synergises with gentamicin and sulfamethoxazole
• Do not use in 1st trimester – teratogenic
• Avoid with other anti-folate drugs → methotrexate

✓ Many gram +ve (inc. MRSA)
✓ Most gram –ve
✗ Pseudomonas; anaerobes

• Indication:
o Lower UTI
• In systemically well patient
• 3 day course females; 7 day course males
o Oral MRSA treatment - Combined with rifampicin or fusidic acid
• SE:
o Nausea, vomiting, diarrhoea
o Suppression of haematopoiesis (contra-indicated: blood dyscrasias)
o  serum creatinine (competitively inhibits tubular secretion of creatinine resulting in temporary – reversed when drug is stopped; no change in GFR)
o Steven Johnson syndrome (co-trimoxazole); Myelosuppresion

25
Metronidazole - examples - mechanism of action - good against? bad for? - caution - clinical uses - SE
• Enters bacterial cell by passive diffusion • In susceptible organism the pro-drug is activated to produce highly reactive metronidazole radicals → de-stabilize nucleic acids and proteins o Bactericidal o Oral or IV o Good penetration into abscesses o Renal excretion o P450 inhibitor • Anaerobes – C. difficile • Parasites – Entamoeba histolytica, Giardia lamblia, Trichomas vaginalis • NOT for non-anaerobic bacteria • Use: o C difficile colitis o Amoebic liver abscesses (& intestinal amoebiasis) o H pylori eradication o Intra-abdominal sepsis (anaerobic cover) o Small bowel bacterial overgrowth o Pelvic inflammatory disease • SE o Metallic taste (common) o Nausea, vomiting, diarrhoea, constipation o Peripheral neuropathy (prolonged use) o Disulfiram-like reaction with alcohol o Headache & dizziness o Cerebellar toxicity with high dose/ prolonged use
26
Group A strep treatment
Penicillins alt = macrocodes Group A strep = strep. pyogenes - catalase negative - cellulitis, strep throat, S SSTI = nec. fas, puerpal sepsis (infection post child birth or miscarriage)
27
bone penetration antibiotic
fluoroquinolones
28
biofilm penetration antibtotics
rifampicin
29
MSSA treatment in prosthetic joint infection
2weeks IV flucloxacillin and rifampicin follow by PO quinolone and rifampicin